AU5227999A - Substituted oxazolines as antiproliferative agents - Google Patents

Substituted oxazolines as antiproliferative agents

Info

Publication number
AU5227999A
AU5227999A AU52279/99A AU5227999A AU5227999A AU 5227999 A AU5227999 A AU 5227999A AU 52279/99 A AU52279/99 A AU 52279/99A AU 5227999 A AU5227999 A AU 5227999A AU 5227999 A AU5227999 A AU 5227999A
Authority
AU
Australia
Prior art keywords
antiproliferative agents
substituted oxazolines
oxazolines
substituted
antiproliferative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU52279/99A
Inventor
Kenneth J. Barr
Akiyo K. Claiborne
Stephen L. Ii Gwaltney
Hwan-Soo Jae
Douglas M. Kalvin
Qun Li
Gang Liu
Hing L. Sham
Le Wang
Keith W. Woods
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of AU5227999A publication Critical patent/AU5227999A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/14Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU52279/99A 1998-07-27 1999-07-23 Substituted oxazolines as antiproliferative agents Abandoned AU5227999A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12297398A 1998-07-27 1998-07-27
US09122973 1998-07-27
PCT/US1999/016782 WO2000006556A1 (en) 1998-07-27 1999-07-23 Substituted oxazolines as antiproliferative agents

Publications (1)

Publication Number Publication Date
AU5227999A true AU5227999A (en) 2000-02-21

Family

ID=22405991

Family Applications (1)

Application Number Title Priority Date Filing Date
AU52279/99A Abandoned AU5227999A (en) 1998-07-27 1999-07-23 Substituted oxazolines as antiproliferative agents

Country Status (2)

Country Link
AU (1) AU5227999A (en)
WO (1) WO2000006556A1 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6849656B1 (en) 1999-09-17 2005-02-01 Baylor University Indole-containing and combretastatin-related anti-mitotic and anti-tubulin polymerization agents
EP2335700A1 (en) 2001-07-25 2011-06-22 Boehringer Ingelheim (Canada) Ltd. Hepatitis C virus polymerase inhibitors with a heterobicylic structure
ITMI20011758A1 (en) * 2001-08-09 2003-02-10 Ciba Sc Holding Ag LIGANDS
WO2003027105A1 (en) * 2001-09-26 2003-04-03 Bayer Pharmaceuticals Corporation Substituted 3-pyridyl thiophenes as c17,20 lyase inhibitors
JP2005529923A (en) 2002-05-13 2005-10-06 イーライ・リリー・アンド・カンパニー Polycyclic compounds for use as melanin-concentrating hormone antagonists in the treatment of obesity and diabetes
EP1866293A1 (en) * 2005-03-31 2007-12-19 UCB Pharma, S.A. Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses
MY144968A (en) 2005-04-11 2011-11-30 Xenon Pharmaceuticals Inc Spiro-oxindole compounds and their uses as therapeutic agents
AR053710A1 (en) 2005-04-11 2007-05-16 Xenon Pharmaceuticals Inc SPIROHETEROCICLIC COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS
RU2009117642A (en) 2006-10-12 2010-11-20 Ксенон Фармасьютикалз Инк. (Ca) APPLICATION OF SPYROXYNDOLIC COMPOUNDS AS A THERAPEUTIC MEDICINES
ES2529434T3 (en) 2007-11-21 2015-02-20 Oxigene, Inc. Method to treat hematopoietic neoplasms
CA2741024A1 (en) 2008-10-17 2010-04-22 Xenon Pharmaceuticals Inc. Spiro-oxindole compounds and their use as therapeutic agents
WO2010045251A2 (en) 2008-10-17 2010-04-22 Xenon Pharmaceuticals, Inc. Spiro-oxindole compounds and their use as therapeutic agents
AR077252A1 (en) 2009-06-29 2011-08-10 Xenon Pharmaceuticals Inc ESPIROOXINDOL COMPOUND ENANTIOMERS AND THEIR USES AS THERAPEUTIC AGENTS
JP5752136B2 (en) 2009-10-14 2015-07-22 ゼノン・ファーマシューティカルズ・インコーポレイテッドXenon Pharmaceuticals Inc. Synthetic methods for spiro-oxindole compounds
CA2784122C (en) * 2009-12-17 2017-10-31 Merial Limited Antiparasitic dihydroazole compounds and compositions comprising same
CN102946859B (en) 2010-02-26 2016-03-02 泽农医药公司 For the pharmaceutical composition of the spiral shell-oxindole compounds of topical and the purposes as therapeutic agent thereof
WO2014089177A2 (en) 2012-12-04 2014-06-12 Massachusetts Institute Of Technology Compounds, conjugates and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines
AU2014228822A1 (en) 2013-03-15 2015-10-01 Memorial Sloan-Kettering Cancer Center HSP90-targeted cardiac imaging and therapy
US9682033B2 (en) 2015-02-05 2017-06-20 Teva Pharmaceuticals International Gmbh Methods of treating postherpetic neuralgia with a topical formulation of a spiro-oxindole compound
EP3337495A4 (en) 2015-08-18 2019-04-10 Mateon Therapeutics, Inc. Use of vdas to enhance immunomodulating therapies against tumors
WO2017197045A1 (en) 2016-05-11 2017-11-16 Movassaghi Mohammad Convergent and enantioselective total synthesis of communesin analogs
US11932650B2 (en) 2017-05-11 2024-03-19 Massachusetts Institute Of Technology Potent agelastatin derivatives as modulators for cancer invasion and metastasis
US10640508B2 (en) 2017-10-13 2020-05-05 Massachusetts Institute Of Technology Diazene directed modular synthesis of compounds with quaternary carbon centers
CN108586443B (en) * 2018-01-31 2019-11-26 佳木斯大学附属第一医院 A kind of drug and preparation method thereof for preventing and treating lung bronchogenic carcinoma
US11535634B2 (en) 2019-06-05 2022-12-27 Massachusetts Institute Of Technology Compounds, conjugates, and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines and uses thereof
WO2022182415A1 (en) 2021-02-24 2022-09-01 Massachusetts Institute Of Technology Himastatin derivatives, and processes of preparation thereof, and uses thereof
CN114656417B (en) * 2022-04-08 2023-10-13 合肥工业大学智能制造技术研究院 Synthesis method and application of chiral oxazoline

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9201274D0 (en) * 1992-01-21 1992-03-11 Norsk Hydro As New compounds
DE4303840A1 (en) * 1992-10-22 1994-08-11 Thomae Gmbh Dr K Arylidene-1-azacycloalkanes and arylalkyl-1-azacycloalkanes, their salts, pharmaceutical compositions containing them and their use, and processes for their preparation

Also Published As

Publication number Publication date
WO2000006556A1 (en) 2000-02-10

Similar Documents

Publication Publication Date Title
AU5227999A (en) Substituted oxazolines as antiproliferative agents
PL347628A1 (en) Herbicidal composition
AU8258698A (en) Isoquinoline-indole compounds as antimicrobial agents
AU4580599A (en) Stable no-delivering compounds
AU4167699A (en) Antimicrobial agents
AU3162199A (en) Copper-containing materials
AU5281299A (en) Herbicidal agents with substituted phenoxysulfonylureas
AU8441798A (en) Tricyclically substituted oxazolidinones
AU2616199A (en) Novel bicyclene-substituted oxazolidinones
AU1424200A (en) Compounds
AU4501699A (en) Aminoazole compounds
AU4900699A (en) Herbicidal composition
AU1434500A (en) Compounds
AU2656799A (en) Metal-thiols as imminomodulating agents
AU7432698A (en) Disinfectant composition
AU5516599A (en) Substituted 3-aryl-pyrazoles
AU1702000A (en) Tool arrangement
AU5757799A (en) Weed-controlling agents
AU3778599A (en) Herbicidal compositions
AU4511499A (en) Substituted cyclooctadepsipeptides
AU6124399A (en) Herbicidal compositions
AUPP003297A0 (en) 4,5-diaryloxazole compounds
AU4507899A (en) Substituted n-aryl-o-alkyl-carbamates
AU6197399A (en) Substituted herbicidal formylaminotriazines
AU5742599A (en) Cyclohexenonquinolinoyl-derivatives as herbicidal agents

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase